<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/815C5EC7-FEF6-4146-BF01-A7601535C8A3"><gtr:id>815C5EC7-FEF6-4146-BF01-A7601535C8A3</gtr:id><gtr:name>University of Montreal</gtr:name><gtr:address><gtr:line1>3000, chemin de la Cote-Sainte-Catherine</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FF638415-5CDD-4BBB-ADC2-43DFB8AE30AB"><gtr:id>FF638415-5CDD-4BBB-ADC2-43DFB8AE30AB</gtr:id><gtr:name>University College Dublin</gtr:name><gtr:address><gtr:line1>Belfield</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Ireland</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/815C5EC7-FEF6-4146-BF01-A7601535C8A3"><gtr:id>815C5EC7-FEF6-4146-BF01-A7601535C8A3</gtr:id><gtr:name>University of Montreal</gtr:name><gtr:address><gtr:line1>3000, chemin de la Cote-Sainte-Catherine</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FF638415-5CDD-4BBB-ADC2-43DFB8AE30AB"><gtr:id>FF638415-5CDD-4BBB-ADC2-43DFB8AE30AB</gtr:id><gtr:name>University College Dublin</gtr:name><gtr:address><gtr:line1>Belfield</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Ireland</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/C210A508-5B6B-49AA-8EBD-E47F087AD374"><gtr:id>C210A508-5B6B-49AA-8EBD-E47F087AD374</gtr:id><gtr:firstName>Manfred</gtr:firstName><gtr:surname>Auer</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_G0802522"><gtr:id>426F1483-F7FC-4D77-9477-070735AEF1D8</gtr:id><gtr:title>Strategic Appointment of Professor Manfred Auer at Edinburgh University</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_G0802522</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2009-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>500100</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College Dublin</gtr:collaboratingOrganisation><gtr:country>Ireland, Republic of</gtr:country><gtr:description>PRIMES: Protein interaction machines in oncogenic EGF receptor signaling</gtr:description><gtr:id>4B310CD6-49CC-42F6-AC95-0B3EB3A232F8</gtr:id><gtr:impact>Shave, S and Auer M (2013). CSBB-ConeExclusion, adapting structure based solution virtual screening to libraries on solid support. Journal of Chemical Information and Modeling in press.</gtr:impact><gtr:outcomeId>CJi3Ui8tpx7-1</gtr:outcomeId><gtr:partnerContribution>Static and dynamic EGFR network development</gtr:partnerContribution><gtr:piContribution>Production of Screening Libraries
Network database: Contribution of inhibitors in EGFR network
Biophysical experiments</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Montreal</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:department>Institute of Research in Immunology and Cancer (IRIC)</gtr:department><gtr:description>Novel Screening Technology</gtr:description><gtr:id>DDAD56A4-2B7A-4152-952F-127A97C70A24</gtr:id><gtr:impact>10 million CAN$ CFI grant on &amp;quot;An Integrated Ultra-High-Throughput Platform for Chemical Systems Biology&amp;quot;, received in November 2012, with me as co-applicant and main contributor of strategy.</gtr:impact><gtr:outcomeId>aYPp97UTaQx-1</gtr:outcomeId><gtr:partnerContribution>IRIC hosts me for several weeks a year to built up joint research portfolio with the institute.</gtr:partnerContribution><gtr:piContribution>Since March 2012 I am an Associate Investigator of the Institute of Research in Immunology and Cancer (IRIC), University of Montreal, Canada.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>42000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Case Studentship (with Cyntellect)/BBSRC</gtr:description><gtr:end>2013-04-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>D4223E76-F6DD-4404-9FF1-F3288AA00D68</gtr:id><gtr:outcomeId>G5qZXLyH6kF0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100097</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>SULSA-MSD-SFC PhD Studentships: &amp;quot;Systematic discovery of small molecule ligands for the human WD40 domain family&amp;quot;, jointly with Mike Tyers</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>Scottish Universities Life Sciences Alliance (SULSA)</gtr:fundingOrg><gtr:id>57BEBFCD-12A5-4B98-8692-137F003E8A72</gtr:id><gtr:outcomeId>e7KXqj4oJSe</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>53700</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Scottish Funding Council</gtr:department><gtr:description>PhD Studentship for Jason Early: &amp;quot;Chemical systems biology in zebrafish&amp;quot; Centre for Neuroregeneration (CMVM), University of Edinburgh</gtr:description><gtr:end>2014-07-02</gtr:end><gtr:fundingOrg>Government of Scotland</gtr:fundingOrg><gtr:id>CF8FBA8E-7E86-4164-9FEB-64815789DF0B</gtr:id><gtr:outcomeId>VSaHR3EPYwB0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>53000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CMVM PhD Studentship for Kris Wilson: &amp;quot;Discovery of next-generation KMO inhibitors using advanced screening technology&amp;quot;</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>2CDEFAA9-69A4-4CE0-9265-CA663963F5C6</gtr:id><gtr:outcomeId>tv88YJivQCS0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100079</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>SULSA-MSD-SFC PhD Studentship: &amp;quot;Combining stem cell and high throughput screening technologies to find new lead compound against alpha synuclein pathogenicity&amp;quot;, jointly with Tilo Kunath</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>Scottish Universities Life Sciences Alliance (SULSA)</gtr:fundingOrg><gtr:id>608C3F8D-B948-49B7-B114-4333925F23C7</gtr:id><gtr:outcomeId>guG5H5FtyST</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>29000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>(SULSA), High Throughput and Fragment Screening Fund, 2012: &amp;quot;Discovery of the next generation of antifungal peptidomimetic inhibitors&amp;quot;, jointly with Nick Read.</gtr:description><gtr:fundingOrg>Scottish Universities Life Sciences Alliance (SULSA)</gtr:fundingOrg><gtr:id>38334CD0-EDD0-4107-8683-4694FEE907F9</gtr:id><gtr:outcomeId>n68jQAaLiVH</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>33820</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Case Studentship with Pfizer: Design, synthesis and validation of Kisspeptin peptidomimetics for clinical development to create new medicines with utility in reproductive health. /Biotechnology and Biological Sciences Research Council (BBSRC) and SULSA</gtr:description><gtr:end>2013-11-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>21D945C2-10B4-44ED-ACC4-96D9E1866D7F</gtr:id><gtr:outcomeId>NCEhDBWCduW0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3460000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Systems Medicine</gtr:description><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:id>14F75939-2AB0-4818-9AA6-41BA67536363</gtr:id><gtr:outcomeId>hrd2pLFxzW50</gtr:outcomeId><gtr:sector>Public</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>600000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Edinburgh HT-NMR Facility</gtr:description><gtr:fundingOrg>Chest Heart &amp; Stroke Scotland</gtr:fundingOrg><gtr:id>CBD727AC-D67A-4F8A-8A2F-45866C4E3CD6</gtr:id><gtr:outcomeId>B76eprV3PrS0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>440000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>DPFS Cyclophilin Inhibitors as Antiviral Therapies&amp;quot;</gtr:description><gtr:end>2011-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>46EE6106-D74D-4CB1-824D-634ECE4557B0</gtr:id><gtr:outcomeId>bDTRaAfafbn0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>20800</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>SULSA High Throughput and Fragment Screening Fund:&amp;quot;Screening for hCINAP inhibitors, an emerging drug target for malignant diseases&amp;quot;, jointly with Sander Grannemann.</gtr:description><gtr:fundingOrg>Scottish Universities Life Sciences Alliance (SULSA)</gtr:fundingOrg><gtr:id>3161F6F3-9424-4220-BE68-D799B684E835</gtr:id><gtr:outcomeId>fdpAxVcQPLi</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30300</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Centre of Systems Biology Grant: &amp;quot;A new purine scaffold based TOBOC library for targeting ATPases and GTPases, production and screening&amp;quot;.</gtr:description><gtr:end>2012-08-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>5D66BFBB-C4E6-4ACB-99EB-9F1278A7DCB4</gtr:id><gtr:outcomeId>kr97cgwgDFf0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>17000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>SULSA Chemistry Catalyst Fund: &amp;quot;Design and production of a tagged one-bead one-compound library (TOBOC Library) of purines as privileged scaffolds for inhibition of many enzyme classes (kinases, ATPases, GTPases, Polymerases) and receptors (GPCRS)&amp;quot;</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>Scottish Universities Life Sciences Alliance (SULSA)</gtr:fundingOrg><gtr:id>29D63181-2A41-470A-8524-151521895E96</gtr:id><gtr:outcomeId>Q7p3tEDiDPK0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Scottish Funding Council</gtr:department><gtr:description>Edinburgh BioQuarter Innovation Competition: &amp;quot;CIRINCA - Computational Iterative Replacement by Insertion of Non Coded Amino acids&amp;quot;.</gtr:description><gtr:fundingOrg>Government of Scotland</gtr:fundingOrg><gtr:id>D2A7FCCB-48AB-463A-962D-E500EB98BB7E</gtr:id><gtr:outcomeId>LznKV5GtzJk0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>781766</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>FP7-HEALTH-2011 Grant, Project Number 278568: PRIMES: Protein interaction machines in oncogenic EGF receptor signaling&amp;quot; (12m euros across 13 participants).</gtr:description><gtr:end>2016-11-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>9432700A-037C-4E37-AB18-58646579B224</gtr:id><gtr:outcomeId>K3vpeRe81s30</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>14618</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>IKTF, synthesis of a small molecular H2-relaxin mimetic using a cell based compound screening strategy/IKTF</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>University of Edinburgh</gtr:fundingOrg><gtr:id>8E333072-1EFC-471D-AE3E-9642C859432B</gtr:id><gtr:outcomeId>bC6ARL4w9Qs0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-11-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Referee for the GIS IBiSA (Infrastrutures en Biologie Sante et Agronomie) Program, France.</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>52002F51-CF1B-4C89-8D58-0C42DF0E7B88</gtr:id><gtr:outcomeId>eEiaJxxwS2Y</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Referee for INRA - Institut National de la Recherche Agronomique, France</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>65A801F3-7274-4529-92C5-9EB1D45EB805</gtr:id><gtr:outcomeId>hKKhTC4UiTH</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Referee for INCA - Institute National du Cancer, France</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>9D989180-2C8A-4E1B-B70E-57C46FCDF145</gtr:id><gtr:outcomeId>ocQCLSbgfeE</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>University of Pittburgh, US, academic and professional evaluation</gtr:description><gtr:geographicReach>North America</gtr:geographicReach><gtr:id>C422F78E-D966-4BDA-BAB0-3554D27DA285</gtr:id><gtr:outcomeId>oEhUUrMP3J3</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Deutsche Forschungsgemeinschaft (DFG): Review panel for planned Collaborative Research Centre 955: Architecture, dynamics and decisions in intracellular networks, TU Dortmund University.</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>0E554A16-0DF5-45D5-A686-71AC17932C70</gtr:id><gtr:outcomeId>mcgBiaBYc4Z</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Referee for The European Leukodystrophy Association (ERA), France</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>5AE65D03-E608-4A7D-BF68-8824D122556E</gtr:id><gtr:outcomeId>EBGwGKfwrgp</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of the Scientific Advisory Board for the OICR-TFRI Selective Therapies Program, of the Ontario Institute for Cancer Research, Canada</gtr:description><gtr:geographicReach>North America</gtr:geographicReach><gtr:id>CAF9C018-A8D0-404D-B91F-41132DC29E96</gtr:id><gtr:outcomeId>REnH83F4jds</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Referee for the French National Research Agency</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>4A407915-B154-4504-A1AE-A266DAA59848</gtr:id><gtr:outcomeId>hB5yiAWdh6T</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>The MorPH software is a fully automated computational platform for the rational and iterative replacement of any coded amino acid with any commercially available or synthetically feasible non-coded amino acid in structurally defined peptide or protein sequences. As input database it uses the complete set of worldwide commercially available non-coding amino acids.</gtr:description><gtr:id>50488A59-0BE6-4745-939B-9D9F67E0A4A8</gtr:id><gtr:impact>The MorPH platform has already led to the development of new, IP free peptidomimetics of a validated cancer target.</gtr:impact><gtr:outcomeId>5463aa51530c77.10520911</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>MorPH</gtr:title><gtr:type>Computer model/algorithm</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A 33000 compound library around a purine core scaffold was produced</gtr:description><gtr:id>61BA3D45-A274-4BBB-825F-66015DB003E9</gtr:id><gtr:impact>Used in screening, primary hits identfied</gtr:impact><gtr:outcomeId>CvZZ8LWndXF</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Purine Library</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>10,000 compound cyclic peptidomimetic library</gtr:description><gtr:id>2B72BB2E-5205-4BE4-A542-14A1D4B6C196</gtr:id><gtr:impact>Screening hits identified in Yeast</gtr:impact><gtr:outcomeId>NAUJ3sShppN</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Cyclic Peptide Thiazolyl Library</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Generic expression vector molecular biology developed for the two tags, single-stranded DNA binding protein and HIS10, several fluorescent proteins positioned at the C- and at the N-terminus of the target, with selected proteolytic cleavage sites.</gtr:description><gtr:id>ADAB0979-7879-41F7-A3C9-EE790E6F36EC</gtr:id><gtr:impact>This technology allows producing all members of a target class in 4 variants with much increased efficiency.</gtr:impact><gtr:outcomeId>5462233406df95.41699949</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>New generic expression vectors for the production of tagged and labelled proteins</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>This is a database and software package for automated stabilization of bioactive peptides</gtr:description><gtr:id>31DF45F5-D1E4-45CB-8272-C81D53F141A1</gtr:id><gtr:impact>New collaboration started with Scripps</gtr:impact><gtr:outcomeId>PhuBdEBVmbD</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>ICB-Morph</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>This new synthetic process which is in the patenting phase enables production of single isomers of rhodamines without complex purification schemes, and therefore, for a fraction of the current price. The scientific community will therefore be able to use better dyes for super resolution imaging, single molecule spectroscopy and many other applications.</gtr:description><gtr:id>D7FD55DC-3DBF-486A-9E37-BBFDD9F92860</gtr:id><gtr:impact>Auer M, Mudd G (2014). Novel Synthetic Route to Functionalized single Isomer Rhodamine dyes European Patent Application, Application Number: 1413685.7, Aug 01.</gtr:impact><gtr:outcomeId>54621d699598d1.56151197</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>A novel synthetic route to single isomer functionalised rhodamine dyes</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Drug combinations: Platform developed which uses publicly available assay information on small molecules along with disease pathway maps to predict combination therapies. Wet-lab validation gearing up, to confirm compound producing a synergistic therapeutic effect. In talks with business development consultant for commercialisation opportunities</gtr:description><gtr:id>3A83F284-6CB7-4CC3-AA17-AB684625DF04</gtr:id><gtr:impact>This project will deliver new and optimized combinations of drugs and hit compounds to target cancer</gtr:impact><gtr:outcomeId>54621c4e63fa45.34366161</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Drug Combinations</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Development of a novel magnetic bead based affinity selection method for FLAG tagged target proteins</gtr:description><gtr:id>4235DA0B-F041-424F-A54F-CD3384849700</gtr:id><gtr:impact>Novel inhibitors identified for a mitochondrial membrane protein</gtr:impact><gtr:outcomeId>5463a7e9339538.75237152</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Magnetic Bead based Affinity Selection (magB)</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A 10000 compound library around the pyrrolone scaffold was produced</gtr:description><gtr:id>EF11D40A-BA57-43F7-977E-BAFC412533B1</gtr:id><gtr:impact>Screening in MRC-DPFS granted project on Cyclophilin inhibitors and hits identified.</gtr:impact><gtr:outcomeId>DYYFyKRz5LX</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Pyrrolone Library</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>24000 peptidomimetics for targeting protein - protein interactions produced and available for screening</gtr:description><gtr:id>9303AC20-AAF4-4F7A-A09A-68B1E883FDF1</gtr:id><gtr:impact>Screening hits for to targets in colorectal cancer became screenable</gtr:impact><gtr:outcomeId>VVvgKze8Xxd</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Trimer Libraries (I)</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>This software allows to determine whether a compound or a library bound to the solid phase, e,g. bead, will bind to a target protein of which the structure is known.</gtr:description><gtr:id>BCF1B64C-2974-4FD0-9A75-C35B65386579</gtr:id><gtr:impact>The application of this software eliminates that a screen is run or an assay is performed with a certain chemical linkage point of binding site will be hindered.
Colleagues in the chemistry community consider this to be a very useful tool for library and screening planning.</gtr:impact><gtr:outcomeId>B3JzkdFRm8n</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>CONE Angle Process</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>The cancer drug Ponatinib identified as inhibitor of the Mycobacterium Tuberculosis Kinase, PknB, by ligand-based repurposing, shown to inhibit mycobacteria by Seattle Biomed</gtr:description><gtr:id>54435C3E-7081-4ECF-A5B9-A3F2F5C6B0E4</gtr:id><gtr:impact>Collaborative effort to expand the chemistry with the producing Biotech company ongoing</gtr:impact><gtr:outcomeId>54621e97073ab1.16754029</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>The cancer drug Ponatinib identified as inhibitor of the Mycobacterium Tuberculosis Kinase, PknB</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A new high yield synthesis for this important reagent to perform click chemistry based labeling has been achieved</gtr:description><gtr:id>0F3DCD05-A6AD-4E4C-B8D8-2FFF8532F42C</gtr:id><gtr:impact>Substantial savings</gtr:impact><gtr:outcomeId>54622121ebc164.41248616</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>High Yield Synthesis of TMR-Azide</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A 330000 compound library around a nitro-pyrimidine scaffold was produced.</gtr:description><gtr:id>4199E9BE-79AD-485D-A692-662DC1C3DF51</gtr:id><gtr:impact>Library screened and hits identified in a SULSA granted project on ribosomal kinases (Sander Grannemann)</gtr:impact><gtr:outcomeId>SdeuVkNqtQE</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Nitropyrimidine library</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Developed a novel cellular affinity selection technology for screening of small molecules against untracktable targets, like intracellular membrane proteins. This technique, termed TAPS assay, reveals apparent binding affinity, cell permeability, toxicity and specificity parameters in one experiment.</gtr:description><gtr:id>2279EECF-6B69-4728-A100-AE65325E9FCC</gtr:id><gtr:impact>This technology has been applied for the confirmation of target engagement of small molecules in relevant cell types for protein-protein interaction partners, for allosteric inhibitors of a kinase, and for a full length mitochondrial membrane protein.</gtr:impact><gtr:outcomeId>5463a89c0d1585.06239793</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>TAPS Assay Technology</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Developed UPS-CONA, a fully integrated screening technology for hit compound identification and mechanistic analysis of the E1-E2-E3-substrate cascades for target protein ubiquitination, patent application submitted.</gtr:description><gtr:id>4AFEB552-B570-4A26-AE81-36CC97878B02</gtr:id><gtr:impact>In collaboration with the Biotech company Vichem (H), the first small molecule modulators of Ube2c, a E2-conjugating enzyme and cancer target were identified.</gtr:impact><gtr:outcomeId>5463a90c40f0d6.06462318</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>UPS-CONA</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A new benzophenone - NHS cross-linker was synthesised and provided to the Rappsilber lab at the University of Edinburgh. It reveals different cross-links compared to usual azirine cross-linker is used.</gtr:description><gtr:id>FE121851-64DD-4724-9588-07D3C9A117DC</gtr:id><gtr:impact>Manuscript to be completed in 2014</gtr:impact><gtr:outcomeId>54621cca9372c6.03227937</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>New benzophenone - NHS cross-linker</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Database for combinatorial chemical library containing multi billion in-silico screenable substances</gtr:description><gtr:id>40E816F0-7179-41C5-8CA7-2E14675BFFB9</gtr:id><gtr:impact>Design and production of new large scale bead based libraries
Identification of a library for a target
Identification of a target for a library
Optimization of clinical development compounds</gtr:impact><gtr:outcomeId>bSfUvggXm9S</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>ICB-Score</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>This new safety catch linker (SCAL-II) has improved properties for bead-based screening, and has a much higher yield synthesis achieved.</gtr:description><gtr:id>FB05D41D-FDAD-487E-B397-5B3D0A137E24</gtr:id><gtr:impact>SCAL-II has allowed new bead based libraries to be produced</gtr:impact><gtr:outcomeId>54621f56e8b2b5.64031466</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>A new and improved version of a safety catch linker for solid-phase chemistry (SCAL-II) produced</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>SESMOS Ltd</gtr:companyName><gtr:description>Investors and co-Founders:(a) Siemens Technology Accelerator, Munich (Germany),(b) Scottish Enterprises. Co-Founder: Manfred Auer.
Company mission: SESMOS Ltd links the acoustic resonator CMOS technology (FBAR) developed at Siemens with the single bead &amp;amp; single molecule screening technology developed in the Auer lab to deliver new chemical modulators for customer drug targets in a thoroughly quality controlled and quantitative process at lower costs compared to competition.</gtr:description><gtr:id>7A751D38-FA45-47A3-A673-4583DF2AE234</gtr:id><gtr:impact>SESMOS Ltd is the &amp;quot;flagship&amp;quot; company of a strategic allience between Scottish Enterprises and Siemens AG / Siemens Technology Accelerator with the aim to increase joint company formations in Scotland. 
In 2013 SESMOS received the next founding round from Scottish Enterprises and Siemens.
Currently, due to technical issues with the FBAR technology, SESMOS Ltd. is discontinued with Mar 2014. Technology back to Siemens Core Technologies for further development.</gtr:impact><gtr:outcomeId>SpYLQ1FvZaL</gtr:outcomeId><gtr:yearCompanyFormed>2011</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication><gtr:id>5B65482E-F2A8-4C3B-97C5-5AF7EE719E12</gtr:id><gtr:title>A Wide-Field Fluorescence Microscope Extension for Ultrafast Screening of One-Bead One-Compound Libraries Using a Spectral Image Subtraction Approach.</gtr:title><gtr:parentPublicationTitle>ACS combinatorial science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/46e96faae16690cbd18337e220a8a142"><gtr:id>46e96faae16690cbd18337e220a8a142</gtr:id><gtr:otherNames>Heusermann W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2156-8944</gtr:issn><gtr:outcomeId>58c2f6c52549e2.64535341</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ECE0F7D4-2B6D-44C4-A5DC-CFFFC11662D5</gtr:id><gtr:title>A direct way of redox sensing.</gtr:title><gtr:parentPublicationTitle>RNA biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/385e44792b74e35f1c6f81bb3e8d2ebb"><gtr:id>385e44792b74e35f1c6f81bb3e8d2ebb</gtr:id><gtr:otherNames>Benoit R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1547-6286</gtr:issn><gtr:outcomeId>qRRUPXFe7s5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2A26182-79DE-43DF-9D89-BA4705AC1329</gtr:id><gtr:title>Single bead labeling method for combining confocal fluorescence on-bead screening and solution validation of tagged one-bead one-compound libraries.</gtr:title><gtr:parentPublicationTitle>Chemistry &amp; biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64a0155657e30865a9520310df9f0f22"><gtr:id>64a0155657e30865a9520310df9f0f22</gtr:id><gtr:otherNames>Hintersteiner M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1074-5521</gtr:issn><gtr:outcomeId>oTrdQPGBSGk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B4CD4BB-F6CB-4017-AA0D-5A6AEE932EDC</gtr:id><gtr:title>Identification of a small molecule inhibitor of importin ? mediated nuclear import by confocal on-bead screening of tagged one-bead one-compound libraries.</gtr:title><gtr:parentPublicationTitle>ACS chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64a0155657e30865a9520310df9f0f22"><gtr:id>64a0155657e30865a9520310df9f0f22</gtr:id><gtr:otherNames>Hintersteiner M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1554-8929</gtr:issn><gtr:outcomeId>XTyNNpY9XAt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D156029B-CCCC-455B-95FA-DD9768232DF4</gtr:id><gtr:title>Identification and X-ray co-crystal structure of a small-molecule activator of LFA-1-ICAM-1 binding.</gtr:title><gtr:parentPublicationTitle>Angewandte Chemie (International ed. in English)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64a0155657e30865a9520310df9f0f22"><gtr:id>64a0155657e30865a9520310df9f0f22</gtr:id><gtr:otherNames>Hintersteiner M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1433-7851</gtr:issn><gtr:outcomeId>546111ce3a6097.67979376</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97F73959-23C1-4C45-9EB6-0AD733BDCC6F</gtr:id><gtr:title>CSBB-ConeExclusion, adapting structure based solution virtual screening to libraries on solid support.</gtr:title><gtr:parentPublicationTitle>Journal of chemical information and modeling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e8b6f856a5218ed6084690cb2530ed4"><gtr:id>5e8b6f856a5218ed6084690cb2530ed4</gtr:id><gtr:otherNames>Shave S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1549-9596</gtr:issn><gtr:outcomeId>s9ktA3yAiR2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB18AA20-BA1A-4137-9911-788461836EDF</gtr:id><gtr:title>Analysis of protein-small molecule interactions by microscale equilibrium dialysis and its application as a secondary confirmation method for on-bead screening.</gtr:title><gtr:parentPublicationTitle>Journal of combinatorial chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d3d5bd8bd9957d5b7b34d0bc443ed6d2"><gtr:id>d3d5bd8bd9957d5b7b34d0bc443ed6d2</gtr:id><gtr:otherNames>Weidemann T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1520-4766</gtr:issn><gtr:outcomeId>GXMt9fx6ivM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC5D9A09-0439-4DDC-A931-BA43AD9CD3DC</gtr:id><gtr:title>The x-ray crystal structure of the first RNA recognition motif and site-directed mutagenesis suggest a possible HuR redox sensing mechanism.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e3f471a1db0d6b971b5ebd4126432b38"><gtr:id>e3f471a1db0d6b971b5ebd4126432b38</gtr:id><gtr:otherNames>Benoit RM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>GU7qrv3kYC7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CADB81FA-6CD1-4C0B-8905-12FDBB2201ED</gtr:id><gtr:title>Bacterial expression of human kynurenine 3-monooxygenase: solubility, activity, purification.</gtr:title><gtr:parentPublicationTitle>Protein expression and purification</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/351bdc8c8becb59d14adc9d737744c16"><gtr:id>351bdc8c8becb59d14adc9d737744c16</gtr:id><gtr:otherNames>Wilson K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1046-5928</gtr:issn><gtr:outcomeId>5461135ca94e88.53231577</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F77ACA2-AF86-4143-A5CF-640CC7CA19B7</gtr:id><gtr:title>Confocal nanoscanning, bead picking (CONA): PickoScreen microscopes for automated and quantitative screening of one-bead one-compound libraries.</gtr:title><gtr:parentPublicationTitle>Journal of combinatorial chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64a0155657e30865a9520310df9f0f22"><gtr:id>64a0155657e30865a9520310df9f0f22</gtr:id><gtr:otherNames>Hintersteiner M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1520-4766</gtr:issn><gtr:outcomeId>i14uVvBxDkc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D2612D17-1AE6-4321-BDB0-B46202142646</gtr:id><gtr:title>UFSRAT: Ultra-fast Shape Recognition with Atom Types--the discovery of novel bioactive small molecular scaffolds for FKBP12 and 11?HSD1.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e8b6f856a5218ed6084690cb2530ed4"><gtr:id>5e8b6f856a5218ed6084690cb2530ed4</gtr:id><gtr:otherNames>Shave S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56e070f9d0da39.70755077</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91C2436E-C2E8-4808-A73A-FF7FF520F08D</gtr:id><gtr:title>A general synthetic route to isomerically pure functionalized rhodamine dyes.</gtr:title><gtr:parentPublicationTitle>Methods and applications in fluorescence</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/340a43a52cca613c37c53f6752280a51"><gtr:id>340a43a52cca613c37c53f6752280a51</gtr:id><gtr:otherNames>Mudd G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2050-6120</gtr:issn><gtr:outcomeId>56e04972a26629.69796764</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49BC8D31-DFF4-42C8-BD9B-72183AE5BDF7</gtr:id><gtr:title>Single-bead, single-molecule, single-cell fluorescence: technologies for drug screening and target validation.</gtr:title><gtr:parentPublicationTitle>Annals of the New York Academy of Sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64a0155657e30865a9520310df9f0f22"><gtr:id>64a0155657e30865a9520310df9f0f22</gtr:id><gtr:otherNames>Hintersteiner M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0077-8923</gtr:issn><gtr:outcomeId>qL6DehbEeF1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C1A99E5-0731-4E8A-8712-809C2292F0D3</gtr:id><gtr:title>Novel 1:1 labeling and purification process for C-terminal thioester and single cysteine recombinant proteins using generic peptidic toolbox reagents.</gtr:title><gtr:parentPublicationTitle>Bioconjugate chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/397504e9c8c2ad8fa467453e0769e88e"><gtr:id>397504e9c8c2ad8fa467453e0769e88e</gtr:id><gtr:otherNames>Portal CF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1043-1802</gtr:issn><gtr:outcomeId>546110199dd6d4.59683352</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C77574C2-5BD7-48B6-9BA3-2516037C12E2</gtr:id><gtr:title>Ablation of the regulatory IE1 protein of murine cytomegalovirus alters in vivo pro-inflammatory TNF-alpha production during acute infection.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e8a7be316809080bd78e2abe1a0a4411"><gtr:id>e8a7be316809080bd78e2abe1a0a4411</gtr:id><gtr:otherNames>Rodr?guez-Mart?n S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>pm_16427_27_22952450</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90246E9B-C77C-469B-BED6-F2A3682492CC</gtr:id><gtr:title>Proximity-dependent initiation of hybridization chain reaction.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75874ea0f805cfd2e19e73267eeafd1e"><gtr:id>75874ea0f805cfd2e19e73267eeafd1e</gtr:id><gtr:otherNames>Koos B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>56e04972821d65.02220548</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CBA491CD-3A52-4660-B411-A205EEE1AD8D</gtr:id><gtr:title>Terminal adenosyl transferase activity of posttranscriptional regulator HuR revealed by confocal on-bead screening.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/22176c0b717f2d65036a898d033a14b6"><gtr:id>22176c0b717f2d65036a898d033a14b6</gtr:id><gtr:otherNames>Meisner NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>iAakvKbMMtZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F4D00B7-2EEE-49E5-9EF5-DD5E545D0A9E</gtr:id><gtr:title>A 7-year dataset for driving and evaluating snow models at an Arctic site (Sodankyl&amp;auml;, Finland)</gtr:title><gtr:parentPublicationTitle>Geoscientific Instrumentation, Methods and Data Systems</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c3070f82f3a449bc3fd380abee390ed5"><gtr:id>c3070f82f3a449bc3fd380abee390ed5</gtr:id><gtr:otherNames>Essery R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>588b6f941ef698.47786184</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E379CE4-2BEE-41BA-B1CD-188024502501</gtr:id><gtr:title>High-throughput chemical screening for antivirulence developmental phenotypes in Trypanosoma brucei.</gtr:title><gtr:parentPublicationTitle>Eukaryotic cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94d6c926287e6cf3c09d56c1a41f5495"><gtr:id>94d6c926287e6cf3c09d56c1a41f5495</gtr:id><gtr:otherNames>MacGregor P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1535-9786</gtr:issn><gtr:outcomeId>546110f9008dc4.45906013</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CDF63B10-09B8-4DDD-B16D-ED666B40C948</gtr:id><gtr:title>A two-channel detection method for autofluorescence correction and efficient on-bead screening of one-bead one-compound combinatorial libraries using the COPAS fluorescence activated bead sorting system.</gtr:title><gtr:parentPublicationTitle>Methods and applications in fluorescence</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64a0155657e30865a9520310df9f0f22"><gtr:id>64a0155657e30865a9520310df9f0f22</gtr:id><gtr:otherNames>Hintersteiner M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2050-6120</gtr:issn><gtr:outcomeId>doi_16427_1_1_017001</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78C9D4D2-BB33-4EB6-898F-8476C314F240</gtr:id><gtr:title>Overexpression of human kynurenine-3-monooxygenase protects against 3-hydroxykynurenine-mediated apoptosis through bidirectional nonlinear feedback.</gtr:title><gtr:parentPublicationTitle>Cell death &amp; disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/351bdc8c8becb59d14adc9d737744c16"><gtr:id>351bdc8c8becb59d14adc9d737744c16</gtr:id><gtr:otherNames>Wilson K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58c2f6c5513ad6.21118650</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38004778-A1D8-44FF-9CF0-8FBC9DD392E4</gtr:id><gtr:title>On-bead screens sample narrower affinity ranges of protein-ligand interactions compared to equivalent solution assays.</gtr:title><gtr:parentPublicationTitle>Chemphyschem : a European journal of chemical physics and physical chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64a0155657e30865a9520310df9f0f22"><gtr:id>64a0155657e30865a9520310df9f0f22</gtr:id><gtr:otherNames>Hintersteiner M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1439-4235</gtr:issn><gtr:outcomeId>pm_16427_27_22829563</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>58F1DA50-8322-4708-B95C-3D4C9EF32FCD</gtr:id><gtr:title>Covalent fluorescence labeling of His-tagged proteins on the surface of living cells.</gtr:title><gtr:parentPublicationTitle>Chembiochem : a European journal of chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64a0155657e30865a9520310df9f0f22"><gtr:id>64a0155657e30865a9520310df9f0f22</gtr:id><gtr:otherNames>Hintersteiner M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1439-4227</gtr:issn><gtr:outcomeId>sJWigNT6CfH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5278A07-B77D-4038-89BB-EA3135F730A5</gtr:id><gtr:title>A magnetic bead-based ligand binding assay to facilitate human kynurenine 3-monooxygenase drug discovery.</gtr:title><gtr:parentPublicationTitle>Journal of biomolecular screening</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/351bdc8c8becb59d14adc9d737744c16"><gtr:id>351bdc8c8becb59d14adc9d737744c16</gtr:id><gtr:otherNames>Wilson K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1087-0571</gtr:issn><gtr:outcomeId>54610fab5bd9d9.03592399</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8012AE36-4A83-4CB1-A002-FD7B10B6A906</gtr:id><gtr:title>A highly potent and cellularly active beta-peptidic inhibitor of the p53/hDM2 interaction.</gtr:title><gtr:parentPublicationTitle>Chembiochem : a European journal of chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64a0155657e30865a9520310df9f0f22"><gtr:id>64a0155657e30865a9520310df9f0f22</gtr:id><gtr:otherNames>Hintersteiner M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1439-4227</gtr:issn><gtr:outcomeId>sFGs2fLqQwR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E78AAC53-3A02-41E9-A699-DE62959DF632</gtr:id><gtr:title>A loss of function analysis of host factors influencing Vaccinia virus replication by RNA interference.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88fec5e04b10d543474d3ab320493439"><gtr:id>88fec5e04b10d543474d3ab320493439</gtr:id><gtr:otherNames>Beard PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>546110662a9de9.45622378</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1A4C11B-D110-43F4-B10E-C57B863B16D3</gtr:id><gtr:title>E2 enzyme inhibition by stabilization of a low-affinity interface with ubiquitin.</gtr:title><gtr:parentPublicationTitle>Nature chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e94754791b4be0de589dc01808c98d92"><gtr:id>e94754791b4be0de589dc01808c98d92</gtr:id><gtr:otherNames>Huang H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1552-4450</gtr:issn><gtr:outcomeId>546112c887f8c4.06031648</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C30CD5E6-4A43-4C30-B6E5-F09347D8A9C9</gtr:id><gtr:title>Identifizierung und Strukturbestimmung eines niedermolekularen Aktivators der LFA-1/ICAM-1-Bindung</gtr:title><gtr:parentPublicationTitle>Angewandte Chemie</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64a0155657e30865a9520310df9f0f22"><gtr:id>64a0155657e30865a9520310df9f0f22</gtr:id><gtr:otherNames>Hintersteiner M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>546110a4a05ba8.44158719</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F279EBA9-3BA4-4399-AD86-328C6EE4D30A</gtr:id><gtr:title>Towards mimicking short linear peptide motifs: identification of new mixed a,?-peptidomimetic ligands for SLAM-Associated Protein (SAP) by confocal on-bead screening.</gtr:title><gtr:parentPublicationTitle>Journal of chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64a0155657e30865a9520310df9f0f22"><gtr:id>64a0155657e30865a9520310df9f0f22</gtr:id><gtr:otherNames>Hintersteiner M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1864-6158</gtr:issn><gtr:outcomeId>EEiGciuxbhy</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8CC4DDE7-0E71-40BA-98E4-01619CD37E7C</gtr:id><gtr:title>Signaling of IL-4R, a typical class I cytokine receptor: What defines the quiescent state?</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd544dee9b93224438065b8e3414cc8b"><gtr:id>bd544dee9b93224438065b8e3414cc8b</gtr:id><gtr:otherNames>Weidemann Thomas</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:isbn>978-0-12-374145-5</gtr:isbn><gtr:outcomeId>BMUiBR11qTT</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_G0802522</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>986F1CAE-CC43-4D59-8F85-A91971E4C4BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Other</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>A056411B-DD7A-4062-BE33-7849FBC9BFA7</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.9  Resources and infrastructure (development of treatments)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>